IR-Med raises $25K via 1.56M shares at $0.016 and warrants at $0.05 exercise

IR-Med, Inc.

Gross proceeds of $25,000 from sale of 1,562,500 shares and 781,250 warrants to purchase common stock.
CEO Ran Ziskind purchased 937,500 shares and 468,750 warrants for $15,000, representing 60% of the offering.
Warrants exercisable immediately at $0.05 per share, expire five years from issuance; securities exempt under Rule 506(b) and Regulation S.
Closing occurred September 16, 2025; securities are unregistered and subject to transfer restrictions.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.